Table 2.
Pathogenetic difference of VMTD between TTP and sepsis-associated TTP-like syndrome
| TTP (GA-VMTD and AA-VMTD) | TTP-like syndrome in sepsis (EA-VMTD) | |
|---|---|---|
| Primary event | Hereditary TTP (GA-VMTD) | Sepsis due to pathogens |
| (due to mutation of ADAMTSD13 gene) | (e.g., bacteria; viruses; fungi; rickettsia; parasites) | |
| Acquired TTP (AA-VMTD) | ↓ | |
| (due to anti-ADAMTS13 antibody) | Complement activation → MAC (C5b-9) formation (?) | |
| ↓ | ↓ | |
| Secondary event | Excess of circulating ULVWF & platelets | C5b-9-induced endotheliopathy |
| ↓ | ↓ | |
| Microthrombogenesis, leading to ULVWF-platelet complex formation in microcirculation | ULVWF released from ECs & anchored to endothelial membrane to recruit platelets → microthrombogenesis | |
| ↓ | ↓ | |
| Tertiary event | Microthrombi in microvasculatures | Microthrombi strings in smaller and larger vasculatures |
| ↓ | ↓ | |
| Final event | Microvascular thrombosis | Vascular microthrombosis |
| ↓ | ↓ | |
| GA-VMTD; AA-VMTD | EA-VMTD | |
| ↓ | ↓ | |
| TTP | TTP-like syndrome |
Abbreviations: ECs endothelial cells, MAC membrane attack complex, TTP thrombotic thrombocytopenic purpura, VMTD vascular microhrombotic disease, AA-VMTD antibody-associated VMTD, EA-VMTD endotheliopathy-associated VMTD, ULVWF unusually large von Willebrand factor multimers